A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
Titel:
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
Auteur:
Greene, Julia M. Schneble, Erika J. Jackson, Doreen O. Hale, Diane F. Vreeland, Timothy J. Flores, Madeline Martin, Jonathan Herbert, Garth S. Hardin, Mark O. Yu, Xianzhong Wagner, Thomas E. Peoples, George E.